Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Urinary Bladder Neoplasms 3Pancreatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neuroblastoma 1Neoplasms 1Ganglioneuroblastoma 1

Interventions

Cyclophosphamide 21Carboplatin 17Etoposide 15Doxorubicin 14Vincristine 13Cisplatin 11Melphalan 10Filgrastim 10Radiotherapy 9Isotretinoin 8Topotecan 7Peripheral Blood Stem Cell Transplantation 6Granulocyte Colony-Stimulating Factor 6dinutuximab 5sargramostim 4etoposide phosphate 4Neoadjuvant Therapy 4Magnetic Resonance Spectroscopy 4Busulfan 4Vindesine 3Thiotepa 3Platinum 3Ifosfamide 3Colony-Stimulating Factors 3Chemotherapy, Adjuvant 3Biopsy 33-Iodobenzylguanidine 31,2-diaminocyclohexaneplatinum II citrate 3liposomal amphotericin B 2fluorodopa F 18 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neuroblastoma × Transurethral Resection of Bladder × Clear all
NCT06172296 2026-05-27

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Recruiting
478 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡